Immediate Sequential Bilateral Cataract Surgery in Patients with Bilateral Visually Significant Cataracts

Area of Science:

• Ophthalmology
• Surgical Innovation
• Patient Outcomes

Background:

• Cataract surgery is a common procedure to restore vision.
• Assessing the safety and efficacy of immediate sequential bilateral cataract surgery (ISBCS) is crucial for patient care.
• Patients with visually significant cataracts and reduced preoperative corrected distance visual acuity (CDVA) require effective treatment options.

Purpose of the Study:

• To evaluate the outcomes of immediate sequential bilateral cataract surgery (ISBCS).
• To assess refractive predictability and visual results after ISBCS in patients with visually significant cataracts.
• To determine the incidence of intraoperative and serious postoperative adverse events following ISBCS.

Main Methods:

• Retrospective review of 1335 patients (2670 eyes) undergoing ISBCS.
• Inclusion criteria: visually significant cataracts and preoperative CDVA ≤20/32.
• Evaluation of refractive and visual outcomes, and adverse events within three months post-surgery.

Main Results:

• 50.2% of eyes achieved uncorrected distance visual acuity (UDVA) ≥20/20, and 89.1% achieved ≥20/32.
• 83.8% of eyes were within ±0.50D of emmetropia; 96.4% within ±1.00D.
• Low incidence of adverse events: 0.524% intraoperative and 2.996% postoperative events per eye. No bilateral CDVA loss.

Conclusions:

• ISBCS demonstrates good refractive predictability in patients with visually significant cataracts.
• The procedure is associated with a low incidence of serious adverse events.
• ISBCS is a safe and effective surgical option for eligible patients.